Introduction

Osteoporosis (OP), the most common systematic bone disorder in elderly individuals1, has a high incidence in current aging societies2. OP is a degenerative bone disease characterized by excessive bone resorption and decreased bone formation, which lead to deterioration of bone microstructure3,4,5. Bone remodeling caused by the action of osteoblasts can repair microfractures and adapt bones to mechanical loads and strains6,7,8. However, deregulation of bone remodeling can lead to bone diseases, including OP. Autophagy is defined as a natural process of self cannibalization that maintains cellular homeostasis by degrading and recycling abnormal cell organelles or macromolecules9. Autophagy is active during the maturation of bone tissue and bone cells and has been revealed to be associated with OP10. Accumulating evidence has demonstrated that autophagy exerts an influence on OP11,12,13,14. Regulation of autophagy is thus a vital factor for OP. However, this mechanism has been incompletely explored in OP.

Long noncoding RNAs (lncRNAs) are a group of noncoding RNAs with a length of 200 or more nucleotides15. It has been revealed that lncRNAs play crucial roles in bone disease16. For instance, the lncRNA NKILA regulates osteogenesis by modulating the RXFP1/AKT signaling pathway17. Another study found that the lncRNA HOTAIRM1 targets the JNK/AP-1 signaling pathway to regulate osteogenic differentiation18. Moreover, the lncRNA HIF1A-AS2 promotes osteogenic differentiation of ADSCs via PI3K/Akt signaling19. RNA sequencing results have demonstrated that the lncRNA PAX8 antisense RNA 1 (PAX8-AS1) is upregulated in peripheral whole blood of patients with OP20. However, the molecular mechanism of PAX8-AS1 in OP remains to be fully explored.

Numerous studies have elucidated that lncRNAs bind to microRNAs (miRNAs) as competing endogenous RNAs (ceRNAs), thereby affecting and regulating the expression of mRNAs21. These lncRNA-mediated ceRNA networks have been revealed to exert profound influences on certain diseases. For example, the lncRNA ANRIL promotes lymphangiogenesis during the diabetic wound healing process by binding with miR-181a to upregulate Prox122. Another study revealed that the lncRNA GAS5 suppresses adipogenic differentiation of MSCs via the miR-18a/CTGF axis23. Additionally, lncRNA-1604 regulates neural differentiation by sponging miR-200c and targeting ZEB24. These reports prompted us to investigate whether the lncRNA PAX8-AS1 regulates the development of OP as a ceRNA; thus, we designed this study.

In the current study, we assumed that PAX8-AS1 may function as a ceRNA and further explored the role and molecular mechanism of PAX8-AS1 in OP. Our report may provide a novel therapeutic strategy for OP.

Materials and methods

Animal grouping and study design

Twenty four 12 week old female Sprague–Dawley rats (105–145 g) were purchased from Cavens Lab Animal Ltd. (Changzhou, China). Rats were housed in individual cages at 26 °C on a 12-h light/dark cycle (relative humidity 50–65%). During the experiments, the “reduction, replacement, and refinement” animal welfare principle was obeyed. Rats were randomly divided into the sham group (sham, n = 12) and ovariectomized model group (OVX, n = 12). Rats in the sham group were anaesthetized by intraperitoneal injection of 5% chloral hydrate at a dose of 400 mg/kg animal body weight. Rats in the OVX group were subjected to the same surgical protocols but with the removal of both ovaries. An AAV vector was generated after cloning small interfering RNA (siRNA) fragments targeting PAX8-AS1 into the adenoviral vector GV478 (Genechem Co., Ltd., Shanghai, China) as previously described25. Rats were injected intraarticularly with this solution with 33-gauge needles (Hamilton Company, Bonaduz, Switzerland) and 25-µl CASTIGHT syringes (Hamilton Company). All procedures were conducted following the recommendations in the Guide for the Care and Use of Laboratory Animals (8th edition, 2011, National Research Council). After being fed for another 6 weeks, the rats were sacrificed by cervical vertebra dislocation, and the proximal tibia and skull were excised and separated. All experimental procedures in the experiments were approved by the Animal Experimental Ethics Committee of The Third Affiliated Hospital of Southern Medical University.

Cell culture and conditioning

The skulls of sham and OVX rats were separated under aseptic conditions and were then covered and digested several times with type I collagenase, and the supernatant was removed. The collected cells were washed twice using Hank’s solution and were then suspended in Dulbecco’s modified Eagle’s medium (DMEM, GIBCO, Grand Island, NY, USA) containing 10% fetal bovine serum (FBS, Sigma–Aldrich, Shanghai, China) and 1% penicillin–streptomycin (Sigma–Aldrich) at 37 °C in 5% CO2. When cell-cell contact was observed, the cells were passaged to remove fibroblasts. The cell suspension was transferred to a glass culture bottle, incubated for 10 min, and then transferred to another culture bottle. This procedure was repeated two or three times. Finally, the osteoblasts were suspended in culture medium.

Cell transfection

The PAX8-AS1 knockdown vector (si-PAX8-AS1) or its negative control vector (si-NC), the G protein subunit beta 1 (GNB1) overexpression vector (pcDNA3.1-GNB1) or its negative control vector (pcDNA3.1-vector), and the microRNA 1252-5p (miR-1252-5p) mimic vector (miR-1252-5p) or its negative control vector (NC mimics) were synthesized by GenePharma (Shanghai, China) and were then transfected into primary osteoblasts. All transfections were performed using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) for 48 h according to the manufacturer’s instructions.

Real time quantitative polymerase chain reaction (RT qPCR) assay

Total RNA was extracted using TRIzol reagent (Invitrogen) and reverse transcribed to complementary DNA (cDNA) using a Takara First-Strand Complementary DNA Synthesis Kit (Takara, Tokyo, Japan). The PCR reagent used to amplify the obtained cDNA (200 ng) was prepared according to the instructions of the Takara RT qPCR Kit (Takara). A SYBR Premix Ex Taq miRNA Kit (Takara) was used to examine the level of miR-1252-5p, and a SYBR Premix Ex TaqTM II Kit (Takara) was used to quantify the expression of PAX8-AS1 and GNB1. Expression levels were analyzed using the 2−ΔΔCt method. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and RNU6 (U6) were used as references for PAX8-AS1 (or GNB1) and miR-1252-5p, respectively. Each experiment was repeated independently three times.

Enzyme linked immunosorbent assay (ELISA)

In this experiment, an avidin-biotin complex enzyme-linked immunosorbent assay (ABC ELISA) was used to determine the contents of C-telopeptide (CTX) and osteocalcin (OCN) in serum, and the procedure followed the instructions in the ELISA Kit (Invitrogen).

Alizarin red staining assay

Osteoblasts were inoculated into 24-well plates and cultured with DMEM containing 10% FBS to a density of 5 × 105 cells per well. The medium was discarded, and the osteoblasts were washed twice with phosphate-buffered saline (PBS). The osteoblasts were fixed with 10% formaldehyde-calcium solution for 10 min and washed with isopropanol for 1 min. The osteoblasts were stained with alizarin red (Leagene, Beijing, China) for 1 min at 37 °C in a dark room. After decolorization, the osteoblasts were counterstained with hematoxylin (Abcam, Cambridge, MA, USA) for 1 min. Finally, the slices were washed with PBS and mounted with glycerin. Then, the slices were visualized under a microscope.

Cell Counting Kit-8 (CCK 8) assay

Osteoblasts were seeded into 96-well plates at 2 × 104 cells/well. Ten microliters of CCK 8 reagent (Beyotime, Shanghai, China) was added per well at the indicated posttransfection time points (24, 48, 72 h). After 2 h of incubation at 37 °C, the optical densities were measured at a spectral wavelength of 450 nm using a microplate reader (Thermo Fisher Scientific, Waltham, MA). Three replicates were analyzed for each time point, and each experiment was repeated independently three times.

Flow cytometric analysis

Apoptosis of transfected osteoblasts was assessed by flow cytometric analysis. Osteoblasts were harvested after transfection for 48 h, and 1 × 105 cells were digested using 0.25% EDTA-free trypsin, washed with precooled PBS three times and collected by centrifugation at 2000 r/min. Then, osteoblasts were washed twice with 5% bovine serum albumin (BSA), and the supernatant was discarded. Subsequently, 300 μl of 5% BSA and 700 μl of 70% precooled alcohol were added to the osteoblast culture. Next, the osteoblasts were centrifuged at 2000 r/min for 5 min, washed and resuspended in PBS, and incubated with 1 μl of RNase A (10 mg/μl) for 20 min. A total of 300 microliters of propidium iodide (PI; 10 μg/ml; Sigma–Aldrich, St. Louis, MO) were used to stain cells for 15 min at 4 °C. Furthermore, apoptosis was measured in accordance with the annexin V-fluorescein isothiocyanate (FITC) apoptosis detection kit instructions (Sigma–Aldrich). In brief, 100 μl of binding buffer and 5 μl of annexin V-FITC (20 μg/ml) were added to each tube, followed by a 15 min incubation in the dark. Next, 150 μl of binding buffer and 10 μl of PI dye (50 μg/ml) were added to the tubes. The apoptosis rate was measured with a FACSCanto II flow cytometer (BD Biosciences, Shanghai, China).

Western blot analysis

Tibial tissues were lysed with radioimmunoprecipitation assay buffer (Cell Signaling Technology, Danvers, MA) containing protease inhibitor cocktail. The concentration of proteins (10 μg per lane) was determined using a Pierce™ BCA Protein Assay Kit. Proteins were separated by sodium dodecyl sulfate–polyacrylamide gel electrophoresis and were then transferred to polyvinylidene difluoride (PVDF) membranes at 15 V for 1 h at low temperature. Membranes were blocked with 5% skim milk for 2 h. Proteins were detected using the following primary antibodies at a 1:1000 dilution overnight at 4 °C: anti-Beclin-1 (ab210498; Abcam, UK), anti-light chain 3B (LC3B; ab48394; Abcam), anti-GNB1 (ab137635; Abcam), anti-autophagy-related 5 (ATG5; ab108327; Abcam), anti-p62 (ab56416; Abcam), anti-Bcl-2 (ab194583; Abcam), anti-Bax (ab32503; Abcam), anti-cleaved caspase 3 (PA5-114687, Thermo Fisher Scientific) and anti-GAPDH (ab9485; Abcam) antibodies. Then, membranes were incubated with horseradish peroxidase-conjugated anti-rabbit IgG (Zsbio) for 2 h at room temperature. Finally, immunoreactions were evaluated with an enhanced chemiluminescence detection system. The protein levels were normalized to those of the corresponding GAPDH loading control. An Alpha Innotech Gel Imager (Alpha Innotech Corporation, San Leandro, CA) was used to visualize the specific bands, and the optical density of each band was measured using Image Pro Plus software (version X; Media Cybernetics, Silver Springs, MD).

Immunofluorescence (IF) staining assay

Green fluorescent protein (GFP)-LC3 adenoviral particles were purchased from Invitrogen. Cells were infected with the adenoviral particles; after infection, the cells were cultured for 24 h. Imaging was performed in an UltraVIEW VoX 3D Imaging System (Perkin-Elmer, Waltham, MA), and all image acquisition settings were held constant during image acquisition.

HE staining

Morphological changes in rat proximal tibias were evaluated by HE staining. The excised proximal tibias were fixed with 10% paraformaldehyde, decalcified with 14% EDTA (Thermo Fisher Scientific) and embedded in paraffin. Then, the bone samples were sectioned into 4 μm slices and stained with hematoxylin for 3 min and 0.5% eosin for 30 s. Images of HE staining were acquired using a microscope.

Subcellular fractionation assay

Cytoplasmic and nuclear extracts were obtained from osteoblasts with NE-PER Nuclear and Cytoplasmic Extraction Reagents (Thermo Scientific, Waltham, MA, USA) according to the manufacturer’s instructions. RNA isolated from the nucleus or cytoplasm was analyzed by RT-qPCR. GAPDH and U6 were used as internal controls.

Luciferase reporter assay

To detect the binding between PAX8-AS1 (or the GNB1 3′ UTR) and miR-1252-5p, the sequences of wild-type PAX8-AS1 (or GNB1 3′ UTR) and mutant PAX8-AS1 (or GNB1 3′ UTR) were cloned into the firefly luciferase reporter vector pmirGLO (Promega, Madison, WI, USA). The plasmid was synthesized by Invitrogen. The pmirGLO-PAX8-AS1 (or pmirGLO-GNB1 3′ UTR)-Wt or pmirGLO-PAX8-AS1 (or pmirGLO-GNB1 3′ UTR)-Mut plasmids were cotransfected with the miR-1252-5p mimic or NC mimic into osteoblasts. After 48 h of transfection, a luciferase reporter assay was performed with a dual-luciferase reporter assay system kit (Promega) according to the manufacturer’s instructions.

RNA immunoprecipitation assay

An RNA immunoprecipitation (RIP) assay was performed to evaluate the relationships among genes in osteoblasts. After cells were lysed with IP buffer (Thermo Fisher Scientific), the cell lysates were centrifuged at 12,000 × g for 30 min, and the supernatant was the collected. Subsequently, 20 µl of protein magnetic beads (Millipore, Darmstadt, Germany) was added and incubated with the lysate overnight at 4 °C with anti-Ago2 antibodies and IgG. Finally, the RNAs purified from the beads using TRIzol reagent were detected using RT-qPCR.

Statistical analysis

GraphPad Prism 6.0 (GraphPad Software Inc., La Jolla, CA) was used for all of the above statistical analyses. The data are shown as the mean ± S.D. vlaues. Gene expression correlations were determined by Spearman correlation analysis. Student’s t-test was used for comparisons between two groups, while one way analysis of variance was used for multigroup comparisons. p < 0.05 was considered to be statistically significant.

Results

PAX8-AS1 was significantly upregulated in the rat model of OP

According to RNA-sequencing results in previous literature, PAX8-AS1 is highly expressed in peripheral whole blood of patients with OP20. We established a rat model of OP by performing ovariectomy to mimic OP in vivo. Serum CTX is a bone resorption marker26,27. OCN is synthesized and produced by osteoblasts, and its level reflects the activity of osteoblasts and the bone turnover rate28,29. Thus, we measured the serum OCN and CTX levels in rats after operation. Compared with those in the sham group, the serum CTX and OCN levels were significantly elevated in the OVX group (Fig. 1a, b). Furthermore, alizarin red staining experiments demonstrated that the alizarin red positive cell count was decreased in the OVX group (Fig. 1c). These results indicated the successful establishment of the rat model of OP. Subsequently, we detected PAX8-AS1 expression in the rat model of OP by RT-qPCR. The results indicated that PAXB-AS1 was upregulated in the OVX group (Fig. 1d).

Fig. 1: Establishment of the rat model of OP and PAX8-AS1 expression in the rat model of OP.
figure 1

a ELISA was used to detect the serum CTX level (mg/ml) in rats under the indicated treatment (n = 6 rats/group). b ELISA was used to measure the serum OCN level (mg/ml) in rats under the indicated treatment (n = 6 rats/group). c The alizarin red-positive cell count was determined using microscopy (magnification: 200×). d RT-qPCR was used to detect PAX8-AS1 expression in rats (n = 6 rats/group) under the indicated treatment. *p < 0.05.

Full size image

Silencing PAX8-AS1 promoted cell viability but attenuated apoptosis and autophagy in osteoblasts

To further investigate the specific biological role of PAX8-AS1 in osteoblasts, in vitro loss-of-function assays were carried out. Before in vitro experiments, the si-NC or si-PAX8-AS1 vectors were transfected into osteoblasts. As a result of transfection, PAX8-AS1 expression in osteoblasts showed a significant decrease (Fig. 2a). First, the CCK-8 assay results showed that PAX8-AS1 knockdown significantly increased the viability of osteoblasts (Fig. 2b). Subsequently, to explore the impact of PAX8-AS1 silencing on osteoblast apoptosis, flow cytometric analysis was conducted. The results suggested that PAX8-AS1 depletion reduced the osteoblast apoptosis rate (Fig. 2c). Moreover, the western blot results revealed that PAX8-AS1 silencing in osteoblasts caused a decrease in the protein expression levels of Beclin-1, LC3 II/I and ATG5 and an increase in the p62 protein expression level (Fig. 2d). Furthermore, IF staining experiments demonstrated that the fluorescence intensity of LC3 was decreased in the si-PAX8-AS1 group (Fig. 2e), which indicated that PAX8-AS1 silencing suppressed autophagy in osteoblasts.

Fig. 2: PAX8-AS1 knockdown promoted cell proliferation and inhibited apoptosis and autophagy.
figure 2

a RT-qPCR was used to measure the transfection efficiency of si-PAX8-AS1. b The viability of proximal tibia osteoblasts with PAX8-AS1 downregulation was examined using a CCK-8 assay. c The apoptosis of osteoblasts after PAX8-AS1 knockdown was assessed by flow cytometric analysis. d Beclin-1, LC3, ATG5 and p62 protein levels in proximal tibia osteoblasts were determined by western blot analysis after PAX8-AS1 silencing. e IF staining was used to evaluate the LC3 level (magnification: 200×) under PAX8-AS1 depletion. *p < 0.05.

Full size image

PAX8-AS1 interacted with miR-1252-5p

The subcellular localization of transcripts is vital for the corresponding gene expression and regulatory processes30,31. Previous evidence has revealed that the subcellular localization of lncRNAs defines their functions32,33. To probe the function of PAX8-AS1 in osteoblasts, PAX8-AS1 localization was determined by a subcellular fractionation assay. The results indicated that PAX8-AS1 was primarily localized in the cytoplasm of osteoblasts (Fig. 3a), indicating that PAX8-AS1 posttranscriptionally regulates gene expression. LncRNAs acting as ceRNAs posttranscriptionally modulate mRNA expression by interacting with shared miRNAs25,34,35,36. Therefore, we assumed that PAX8-AS1 exerts its regulatory effects in osteoblasts by functioning as a ceRNA. Through bioinformatic analysis, 5 potential miRNAs were identified (condition: CLIP data > =3, high stringency). Simultaneously, the RT-qPCR results revealed that only miR-1252-5p was downregulated in the OVX group (Fig. 3b). Subsequently, the RT-qPCR analysis results indicated that miR-1252-5p expression was elevated in osteoblasts after transfection of the miR-1252-5p mimic vector (Fig. 3c). Moreover, the binding sequence between miR-1252-5p and PAX8-AS1 was predicted by a bioinformatics approach (Fig. 3d). The luciferase reporter assay results showed that the miR-1252-5p mimic decreased the luciferase activity of osteoblasts containing the PAX8-AS1-Wt vector and had no significant influence on the luciferase activity of osteoblasts containing the PAX8-AS1-Mut vector (Fig. 3e). Furthermore, Spearman correlation analysis revealed that PAX8-AS1 expression was negatively associated with miR-1252-5p expression in the proximal tibia of rats (Fig. 3f).

Fig. 3: PAX8-AS1 interacted with miR-1252-5p.
figure 3

a A subcellular fractionation assay was used to identify the localization of PAX8-AS1 in osteoblasts. b Putative miRNAs with binding sites in PAX8-AS1 were predicted by the starBase database, and RT-qPCR was used to measure the expression levels of candidate miRNAs in the rat model of OP to filter the miRNAs. c RT-qPCR analysis was used to examine the transfection efficiency of the miR-1252-5p mimic. d The binding site between PAX8-AS1 and miR-1252-5p was obtained by a bioinformatics approach. e The binding ability of PAX8-AS1 and miR-1252-5p was explored using a luciferase reporter assay. (f) Spearman correlation analysis was used to investigate the relationship of PAX8-AS1 and miR-1252-5p expression in the rat proximal tibia. *p < 0.05, **p < 0.01, ***p < 0.001, ns: not significant.

Full size image

GNB1 was negatively targeted by miR-1252-5p

To further validate our ceRNA hypothesis, targets of miR-1252-5p were identified from the miRDB database. The ten mRNAs with the highest binding scores were selected for further exploration. The RT-qPCR results suggested that among the 10 candidates, only GNB1 presented a significant reduction in expression in response to miR-1252-5p upregulation (Fig. 4a). The western blot analysis results indicated that the GNB1 protein level was significantly decreased by miR-1252-5p overexpression (Fig. 4b). In addition, via a bioinformatics approach, we identified the binding sequence for miR-1252-5p in the 3′ UTR of GNB1 (Fig. 4c). The luciferase reporter assay results indicated that the luciferase activity of GNB1 3′ UTR-Wt was reduced by miR-1252-5p upregulation, but the luciferase activity of GNB1 3′ UTR-Mut did not show evident alteration in response to miR-1252-5p overexpression (Fig. 4d). Moreover, Spearman correlation analysis indicated a negative association between GNB1 and miR-1252-5p expression and a positive correlation between GNB1 and PAX8-AS1 expression in the proximal tibia of rats (Fig. 4e, f). The regulation of GNB1 by PAX8-AS1 was further explored using RT-qPCR and western blot analyses. The results indicated that the mRNA and protein levels of GNB1 were significantly decreased after PAX8-AS1 silencing (Fig. 4g). RIP assays showed that PAX8-AS1, miR-1252-5p and GNB1 were enriched in the anti-Ago2 precipitates, which indicated that they coexisted in the RNA-induced silencing complex (Fig. 4h). Then, we assessed GNB1 expression in OP rats. GNB1 was demonstrated to be upregulated in the OVX group compared with the sham group (Fig. 4i).

Fig. 4: GNB1 was targeted by miR-1252-5p.
figure 4

a Potential target mRNAs of miR-1252-5p were predicted with the miRDB database, and the changes in the candidate mRNA levels in response to miR-1252-5p overexpression were measured by RT-qPCR to filter the mRNAs. b Western blot analysis was used to determine the GNB1 protein level in osteoblasts after miR-1252-5p upregulation. c The target sequence of miR-1252-5p in the 3′ UTR of GNB1 was obtained by a bioinformatics approach. d A luciferase reporter assay was used to investigate the binding ability of GNB1 and miR-1252-5p. e, f The expression correlation between GNB1 and miR-1252-5p or GNB1 and PAX8-AS1 in the rat proximal tibia was evaluated by Spearman correlation analysis. g The mRNA and protein expression levels of GNB1 after PAX8-AS1 silencing were determined by RT-qPCR and western blotting. h A RIP assay was used to explore the relationship among PAX8-AS1, miR-1252-5p, and GNB1. i GNB1 expression in OVX group and sham group rats. *p < 0.05.

Full size image

PAX8-AS1 promoted apoptosis and activated autophagy by upregulating GNB1

The western blot results suggested that the GNB1 protein level in osteoblasts was significantly increased after transfection with pcDNA3.1-GNB1 (Fig. 5a). LncRNAs participate in various biological processes in human disease by sequestering miRNAs to regulate mRNA expression37,38,39. To verify whether PAX8-AS1 performs its regulatory function in this manner, we performed a series of rescue assays, as follows. First, GNB1 overexpression counteracted the PAX8-AS1 knockdown-mediated increase in the viability of osteoblasts (Fig. 5b). Additionally, the PAX8-AS1 depletion-mediated decrease in osteoblast apoptosis was abolished by GNB1 upregulation (Fig. 5c). The decreased protein levels of Beclin-1, LC3 II/I and ATG5 and the increased protein level of p62 after PAX8-AS1 downregulation were recovered by GNB1 overexpression (Fig. 5d, e). Furthermore, GNB1 elevation reversed the PAX8-AS1 knockdown-mediated reduction in the fluorescence intensity of LC3 (Fig. 5f).

Fig. 5: The PAX8-AS1/miR-1252-5p/GNB1 axis regulated osteoblast function.
figure 5

a Western blot analysis of the GNB1 protein level after transfection of pcDNA3.1-GNB1. b A CCK-8 assay was used to measure the viability of osteoblasts after the indicated transfection. c Flow cytometric analysis was used to examine the apoptosis of osteoblasts in each group. d, e The protein levels of Beclin-1, LC3, ATG5 and p62 in osteoblasts were assessed using western blotting after the indicated transfection. f IF staining revealed the expression level of LC3 (magnification: 200×) in each group. *p < 0.05, **p < 0.01.

Full size image

PAX8-AS1 knockdown alleviated OP by promoting osteoblast differentiation and inhibiting osteoblast autophagy

To further explore how PAX8-AS1 regulates OP progression, in vivo loss-of-function assays were performed in the rat model of OP. AAV containing the si-NC vector or si-PAX8-AS1 vector was injected into OP rats. The RT-qPCR results indicated that PAX8-AS1 expression was significantly reduced by AAV-si-PAX8-AS1 injection (Fig. 6a). As shown in Fig. 6b, c, the serum CTX and OCN concentrations in the OVX group were decreased by PAX8-AS1 knockdown. The protein levels of CTX and OCN were elevated in the OVX group, and these increases were reversed by PAX8-AS1 knockdown (Fig. 6d). The alizarin red staining assay revealed that the number of alizarin red positive cells was decreased in the OVX group after PAX8-AS1 depletion (Fig. 6e). Additionally, the western blot results showed that silencing PAX8-AS1 decreased the Beclin-1, LC3 II/I and ATG5 levels and increased the p62 level in the OVX group (Fig. 6f–h). The expression of proteins related to apoptosis was detected by western blotting. The results indicated that the Bcl-2 protein level was decreased and the Bax and cleaved caspase 3 levels were increased in the OVX group, and all of these changes were reversed by silencing of PAX8-AS1 (Fig. 6i). Hematoxylin/eosin (HE) staining images of the proximal tibia showed that bone microarchitecture deterioration in OP rats was attenuated by PAX8-AS1 silencing (Fig. 6j).

Fig. 6: PAX8-AS1 regulated the OP progression.
figure 6

a RT-qPCR was used to examine the overexpression efficiency after injection of AAV-si-PAX8-AS1 into the proximal tibia. b The serum CTX content under PAX8-AS1 silencing was evaluated using ELISA. c ELISA was used to detect the serum OCN content after PAX8-AS1 depletion. d The protein expression of CTX and OCN in tissues of rats in the sham and OVX groups after PAX8-AS1 knockdown. e The alizarin red positive cell count in the proximal tibia under PAX8-AS1 downregulation was determined by microscopy (magnification: 200×). f–h Western blot analysis revealed the protein levels of Beclin-1, LC3, ATG5 and p62 after PAX8-AS1 knockdown. i The protein levels of Bcl-2, Bax and cleaved caspase 3 in rat tissues after PAX8-AS1 silencing in the indicated groups. j Hematoxylin/eosin (HE) staining images of the proximal tibia in the indicated groups. *p < 0.05.

Full size image

In conclusion, PAX8-AS1 promoted osteoblast apoptosis and autophagy and suppressed osteoblast viability by binding with miR-1252-5p to upregulate GNB1 during osteoporosis progression (Fig. 7).

Fig. 7: The mechanism by which PAX8-AS1 regulated osteoblast viability, autophagy and apoptosis.
figure 7

PAX8-AS1 promoted osteoblast apoptosis and autophagy and reduced osteoblast viability by sponging miR-1252-5p and targeting GNB1.

Full size image

Discussion

OP, characterized by an imbalance between bone resorption by osteoclasts and bone formation by osteoblasts in bone remodeling, is an osteolytic disease affecting millions of people worldwide40,41. In our study, we established a rat model of OP to mimic OP characteristics. We found that the CTX and OCN levels were increased in the OVX group. Moreover, the alizarin red-positive cell count was decreased in the OVX group.

LncRNAs are related to the progression of various diseases42,43,44, including bone diseases. For example, lncAIS silencing in mesenchymal stem cells is related to the pathogenesis of adolescent idiopathic scoliosis45. ZFAS1 promotes chondrocyte proliferation and represses apoptosis and matrix synthesis in osteoarthritis46. Moreover, HOTAIR is associated with degenerative changes in intervertebral discs47. The lncRNA PAX8-AS1 is upregulated in peripheral whole blood of patients with OP20. In our study, the RT-qPCR results showed that PAX8-AS1 was highly expressed in the rat model of OP. Through in vitro loss-of-function assays in osteoblasts, we found that PAX8-AS1 silencing inhibited osteoblast apoptosis and inactivated osteoblast autophagy.

As previously reported, the subcellular localization is essential for RNAs and proteins to play their biological roles48. Indeed, the subcellular localization of lncRNAs seems highly informative regarding their biological functions49. Based on the cytoplasmic localization of PAX8-AS1, we verified that this lncRNA is a posttranscriptional regulator of gene expression. The ceRNA network shows the complex network of all transcribed RNAs, including lncRNAs, which function as miRNA molecular sponges to suppress miRNA function and regulate mRNA expression50. As reported, the lncRNA PAX8-AS1 regulates podocyte apoptosis in diabetic nephropathy via the miR-17-5p/STAT3 axis51. Therefore, we explored whether PAX8-AS1 performs its regulatory function in osteoblasts via a ceRNA network. Through bioinformatic analysis and mechanistic experiments, miR-1252-5p was demonstrated to bind with PAX8-AS1. PAX8-AS1 expression was negatively correlated with miR-1252-5p expression in the proximal tibia of rats. To verify the hypothesis that a ceRNA network is established, we investigated the target of miR-1252-5p. As reported, GNB1 was associated with bone marrow lesions52. Herein, through bioinformatic analysis, GNB1 was identified and confirmed as a potential downstream target gene of miR-1252-5p. Mechanistically, miR-1252-5p directly targeted the GNB1 3′ UTR to decrease GNB1 expression and inhibit GNB1 translation. Moreover, GNB1 expression was negatively correlated with miR-1252-5p in the proximal tibia of rats. Furthermore, rescue assays were performed to explore the function of the PAX8-AS1/miR-1252-5p/GNB1 in osteoblasts. We found that GNB1 upregulation reversed the suppressive impact of PAX8-AS1 silencing on osteoblast apoptosis and autophagy. Moreover, the results of in vivo assays demonstrated that PAX8-AS1 knockdown inhibited apoptosis in OP, thereby mitigating OP.

In conclusion, in the present study, we identified upregulation of PAX8-AS1 in OP. PAX8-AS1 depletion enhanced cell viability and inhibited autophagy and apoptosis in osteoblasts via the miR-1252-5p/GNB1 axis. Our findings may provide a potential novel direction for the clinical treatment of OP.